Skip to main content

Table 1 Patient and pharmacokinetic data for oseltamivir carboxylate in children receiving oral oseltamivir twice a day

From: Pharmacokinetics of oseltamivir in infants under the age of 1 year

Patient number Age
months (m) and days (d)
Sex Weight
(kg)
Dose
(mg/kg/dose)
Dose cycle Cmax
(ng/mL)
Tmax
(h)
AUC0−t
(ng h/mL)
Time for AUC
(h)
No. plasma samples
1 6 m, 23 d F 9.05 3 6 772 9.4 6376 0–9.4 5
2 5 m, 13 d F 9.30 3 6 1960 5.8 18,816 0–10 5
3 11 m, 15 d F 5.69 3 7 443 3.7 1747 3.7–6 2
4 3 m, 13 d M 6.43 2.35 8 466 11.5 2156 5–11.5 2